First Light Asset Management, LLC
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1600004
EDINA, MN
Position in CRNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$39,576,814
-$16,016,128 QoQ
Shares Held
1,089,670
-8.8% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
3.55%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026First Light Asset Management, LLC holds $443,596,929 across 15 Biotechnology names. CRNX ranks #4 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PVLA |
Palvella Therapeutics, Inc.
|
980,758 | $122,251,484 | |
| 2 | CNTA |
Centessa Pharmaceuticals plc
|
1,560,991 | $62,002,562 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
576,684 | $48,539,492 | |
| 4 | CRNX |
Crinetics Pharmaceuticals, Inc.
This page
|
1,089,670 | $39,576,814 | |
| 5 | EWTX |
Edgewise Therapeutics, Inc.
|
1,001,846 | $31,558,149 | |
| 6 | ANAB |
Anaptysbio, Inc
|
565,431 | $31,358,803 | |
| 7 | TECX |
Tectonic Therapeutic, Inc.
|
647,743 | $20,021,736 | |
| 8 | SEPN |
Septerna, Inc.
|
732,860 | $17,610,625 |
All Filings in CRNX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $39,576,814 | 1,089,670 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $55,592,942 | 1,194,263 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $39,214,141 | 941,516 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $24,852,551 | 864,136 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $28,690,753 | 855,419 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $45,273,211 | 885,453 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $48,218,522 | 943,611 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $53,770,753 | 1,200,508 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $79,117,185 | 1,690,177 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $70,724,927 | 1,987,772 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $47,088,204 | 1,583,329 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $28,061,140 | 1,557,222 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $26,003,147 | 1,619,125 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $24,326,427 | 1,329,313 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $26,448,245 | 1,346,652 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $23,137,357 | 1,240,609 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $12,791,735 | 582,767 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $7,750,134 | 272,796 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||